首页> 美国卫生研究院文献>Cardiovascular Diseases >Anticoagulation with Bivalirudin during Deep Hypothermic Circulatory Arrest in a Patient with Heparin-Induced Thrombocytopenia
【2h】

Anticoagulation with Bivalirudin during Deep Hypothermic Circulatory Arrest in a Patient with Heparin-Induced Thrombocytopenia

机译:肝素诱导的血小板减少症患者深低温循环中止期间使用比伐卢定的抗凝作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heparin-induced thrombocytopenia is a well-recognized complication of anticoagulation with heparin. We present the case of a patient with recent heparin-induced thrombocytopenia who subsequently needed surgery on an emergency basis for acute type A aortic dissection. This article reports the successful use of bivalirudin, a direct thrombin inhibitor, as an alternative to heparin throughout cardiopulmonary bypass and deep hypothermic circulatory arrest. We contend that bivalirudin is a safe alternative to heparin when performing surgery for aortic dissection and should be considered as an option for use in patients who present with heparin-induced thrombocytopenia.
机译:肝素诱导的血小板减少是公认的肝素抗凝并发症。我们介绍了一例近期肝素诱导的血小板减少症患者,随后需要急诊进行急性A型主动脉夹层手术。本文报道了在体外循环和深低温循环性阻滞中成功应用比伐卢定(一种直接的凝血酶抑制剂)替代肝素的成功方法。我们认为,在进行主动脉夹层手术时,比伐卢定是肝素的安全替代品,应被视为肝素诱导的血小板减少症患者的一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号